Laparoscopic cholecystectomy after endoscopic trans-papillary gallbladder stenting for acute cholecystitis: a pilot study of surgical feasibility.

Acute cholecystitis Elective surgery Endoscopic trans-papillary gallbladder stenting Gallbladder drainage Laparoscopic cholecystectomy Percutaneous transhepatic gallbladder drainage

Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
07 Apr 2021
Historique:
received: 29 11 2020
accepted: 28 03 2021
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 13 4 2021
Statut: epublish

Résumé

Percutaneous transhepatic gallbladder drainage (PTGBD) is indicated for patients with acute cholecystitis (AC) who are not indicated for urgent surgery, but external tubes reduce quality of life (QOL) while waiting for elective surgery. The objective of the present study was to investigate the feasibility of laparoscopic cholecystectomy after endoscopic trans-papillary gallbladder stenting (ETGBS) comparing with after PTGBD. Intraoperative and postoperative outcomes of patients with ETGBS and PTGBD were retrospectively compared. Eighteen ETGBS and ten PTGBD patients were compared. Differences in the duration of ETGBS and PTGBD [median 209 min (range 107-357) and median 161 min (range 130-273), respectively, P = 0.10], median blood loss [ETGBS 2 (range 2-180 ml) and PTGBD 24 (range 2-100 ml), P = 0.89], switch to laparotomy (ETGBS 11% and PTGBD 20%, P = 0.52), and median postoperative hospital stay [ETGBS 8 (range 4-24 days) and ETGBS 8 (range 4-16 days), P = 0.99]. Thickening of the cystic duct that occurred in 60% of the ETGBS patients and none of the PTGBD patients (P = 0.005) interfered with closure of the duct by clipping. No obstruction occurred in ETGBS patients. ETGBS did not make laparoscopic cholecystectomy less feasible than after PTGBD. This is a pilot study, and further investigations are needed to validate the results of the present study.

Sections du résumé

BACKGROUND BACKGROUND
Percutaneous transhepatic gallbladder drainage (PTGBD) is indicated for patients with acute cholecystitis (AC) who are not indicated for urgent surgery, but external tubes reduce quality of life (QOL) while waiting for elective surgery. The objective of the present study was to investigate the feasibility of laparoscopic cholecystectomy after endoscopic trans-papillary gallbladder stenting (ETGBS) comparing with after PTGBD.
METHODS METHODS
Intraoperative and postoperative outcomes of patients with ETGBS and PTGBD were retrospectively compared.
RESULTS RESULTS
Eighteen ETGBS and ten PTGBD patients were compared. Differences in the duration of ETGBS and PTGBD [median 209 min (range 107-357) and median 161 min (range 130-273), respectively, P = 0.10], median blood loss [ETGBS 2 (range 2-180 ml) and PTGBD 24 (range 2-100 ml), P = 0.89], switch to laparotomy (ETGBS 11% and PTGBD 20%, P = 0.52), and median postoperative hospital stay [ETGBS 8 (range 4-24 days) and ETGBS 8 (range 4-16 days), P = 0.99]. Thickening of the cystic duct that occurred in 60% of the ETGBS patients and none of the PTGBD patients (P = 0.005) interfered with closure of the duct by clipping. No obstruction occurred in ETGBS patients.
CONCLUSION CONCLUSIONS
ETGBS did not make laparoscopic cholecystectomy less feasible than after PTGBD. This is a pilot study, and further investigations are needed to validate the results of the present study.

Identifiants

pubmed: 33827521
doi: 10.1186/s12893-021-01182-7
pii: 10.1186/s12893-021-01182-7
pmc: PMC8028236
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

184

Références

Gastrointest Endosc. 2015 Jan;81(1):111-8
pubmed: 25527052
Gastrointest Endosc. 1990 Sep-Oct;36(5):523-5
pubmed: 2227333
Gastrointest Endosc. 1993 Sep-Oct;39(5):645-51
pubmed: 8224686
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):55-72
pubmed: 29045062
Endoscopy. 2020 Feb;52(2):96-106
pubmed: 31645067
Gastrointest Endosc Clin N Am. 2019 Apr;29(2):293-310
pubmed: 30846154
Gastrointest Endosc. 1994 Jul-Aug;40(4):523
pubmed: 7926557
Semin Gastrointest Dis. 2003 Oct;14(4):165-77
pubmed: 14719767
Endoscopy. 1991 Jan;23(1):2-3
pubmed: 2009832
Endoscopy. 1993 Aug;25(6):392-5
pubmed: 8404707
Scand J Gastroenterol. 2016;51(4):472-8
pubmed: 26595503
Gastroenterology. 1978 Mar;74(3):554-9
pubmed: 415929
Dig Endosc. 2018 Jul;30(4):501-507
pubmed: 29399891
Br J Surg. 1999 Dec;86(12):1521-5
pubmed: 10594498
Orv Hetil. 1994 Jan 23;135(4):185-7
pubmed: 8290244
Surg Gynecol Obstet. 1976 Jul;143(1):56-60
pubmed: 936049
Gastrointest Endosc. 2002 Nov;56(5):753-5
pubmed: 12397293
Surg Endosc. 2019 Nov;33(11):3567-3577
pubmed: 31350611
Br J Surg. 2006 Aug;93(8):987-91
pubmed: 16739098
Gastroenterol Clin Biol. 1997;21(11):854-8
pubmed: 9587537
J Hepatobiliary Pancreat Surg. 2006;13(2):80-5
pubmed: 16547666
Am J Surg. 2002 Jan;183(1):62-6
pubmed: 11869705

Auteurs

Fumihiro Kawano (F)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Ryuji Yoshioka (R)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Yu Gyoda (Y)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Hirofumi Ichida (H)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Tomoya Mizuno (T)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Shigeto Ishii (S)

Department of Gastroenterology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Toshio Fujisawa (T)

Department of Gastroenterology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Hiroshi Imamura (H)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Yoshihiro Mise (Y)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Hiroyuki Isayama (H)

Department of Gastroenterology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Akio Saiura (A)

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. a-saiura@juntendo.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH